Evidence map›Paper›PMID 39789551›Full record

ArticleImplementation science : IS2025

Optimizing vaccine uptake in sub-Saharan Africa: a collaborative COVID-19 vaccination campaign in Madagascar using an adaptive approach.

Viola Pavoncello, Irina Kislaya, Diavolana Koecher Andrianarimanana, Valentina Marchese, Rivo Rakotomalala, Tahinamandranto Rasamoelina, Simon Veilleux, Ariane Guth, Alexina Olivasoa Tsiky Zafinimampera, Sonya Ratefiarisoa and 9 more

Abstract read
In one paragraph

Article in Implementation science : IS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Viola Pavoncello *Research group: Implementation Research, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
Irina Kislaya *German Centre for Infection Research (DZIF), Hamburg-Borstel-Lübeck-Riems, Germany.
Diavolana Koecher AndrianarimananaCentre Hospitalier Universitaire (CHU) Androva, Mahajanga, Madagascar.
Valentina MarcheseResearch group: Implementation Research, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
Rivo RakotomalalaCentre Hospitalier Universitaire (CHU) Androva, Mahajanga, Madagascar.
Tahinamandranto RasamoelinaCentre d' Infectiologie Charles Mérieux (CICM), University of Antananarivo, 101, Antananarivo, Madagascar.
Simon VeilleuxResearch group: Implementation Research, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
Ariane GuthResearch group: Implementation Research, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
Alexina Olivasoa Tsiky ZafinimamperaCentre Hospitalier Universitaire (CHU) Androva, Mahajanga, Madagascar.
Sonya RatefiarisoaCentre Hospitalier Universitaire (CHU) Androva, Mahajanga, Madagascar.
Olivette TotofotsyCentre Hospitalier Universitaire (CHU) Androva, Mahajanga, Madagascar.
Cheick Oumar DoumbiaDepartment of Infectious Diseases Epidemiology, Bernhard Nocht Institute for Tropical Medicine, Bernhard-Nocht-Strasse 74, 20359, Hamburg, Germany.
Rivomalala RakotonavalonaVaccination Program, Ministry of Public Health, Antananarivo, Madagascar.
Holinirina RamananjanaharyUnit for the Coordination of the Covid-19 Vaccination, Ministry of Public Health, Antananarivo, Madagascar.
Zely Arivelo RandriamanantanyMinistry of Public Health, Antananarivo, Madagascar.
Jürgen MayGerman Centre for Infection Research (DZIF), Hamburg-Borstel-Lübeck-Riems, Germany.
Rivo Andry RakotoariveloDepartment of Infectious Diseases, University of Fianarantsoa Andrainjato, 301, Fianarantsoa, Madagascar.
Dewi Ismajani Puradiredja *Department of Infectious Diseases Epidemiology, Bernhard Nocht Institute for Tropical Medicine, Bernhard-Nocht-Strasse 74, 20359, Hamburg, Germany.
Daniela Fusco *Research group: Implementation Research, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany. fusco@bnitm.de.ORCID 0000-0001-8833-239X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe COVID-19 pandemic has highlighted the need for more effective immunization programs, including in limited resource settings. This paper presents outcomes and lessons learnt from a COVID-19 vaccination campaign (VC), which used a tailored adaptive strategy to optimise vaccine uptake in the Boeny region of Madagascar.

methodsGuided by the Dynamic Sustainability Framework (DSF), the VC implementation was regularly reviewed through multi-sectoral stakeholder feedback, key informant interviews, problem-solving meetings, and weekly monitoring of outcome indicators to identify and apply key adaptations. Qualitative data on processes were collected and analysed using a rapid assessment approach. Outcome indicators, including pre- and post-VC vaccine hesitancy and trends in vaccine doses administered, were analysed using generalized linear models. Additionally, vaccination coverage, geographic reach, and target population characteristics, and sustainability indicators, such as staff trained, facilities equipped, and degree of integration of operational and educational materials were also tracked.

resultsKey strategy adaptations included using a proactive campaign approach, community-led awareness and outreach, particularly in remote areas, and addressing cold chain, waste management, vaccine transport, and information technology (IT) equipment gaps. Over six months, 24,888 COVID-19 vaccines were administered. The adapted strategy led to an 8% increase in doses administered weekly (RR = 1.08, CI 95%: 1.01-1.15). However, vaccine hesitancy among the unvaccinated population remained unchanged (∆ = 0.02, CI 95%: -0.04-0.08). In terms of sustainability, 340 staff were trained, and 10 primary healthcare facilities were equipped and refurbished.

conclusionsImplementing collaborative, multi-sectoral vaccination strategies that integrate healthcare services with proactive outreach and community-driven campaigns are effective in increasing vaccine coverage in resource-limited settings. It demonstrates how theory-based adaptive strategies can enhance vaccination rates, even if they do not significantly impact COVID-19 vaccine hesitancy within the community. More generally, this initiative has important implications for adult vaccination programmes other than those related to COVID-19.

Indexed as

COVID-19COVID-19 VaccinesImmunization ProgramsSARS-CoV-2Vaccination CoverageAdolescentAdultFemaleHumansImplementation ScienceMadagascarMaleMiddle AgedVaccinationVaccination HesitancyYoung AdultCOVID-19 VaccinesCapacity strengtheningCOVID-19Dynamic Sustainability FrameworkResource-limited settingsVaccination campaignsVaccine uptake

Identifiers

PMID39789551
PMCPMC11720884

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.